BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 17981792)

  • 1. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.
    Löseke S; Grage-Griebenow E; Heine H; Wagner A; Akira S; Bauer S; Bufe A
    Scand J Immunol; 2006 Apr; 63(4):264-74. PubMed ID: 16623926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.
    Edwards AD; Diebold SS; Slack EM; Tomizawa H; Hemmi H; Kaisho T; Akira S; Reis e Sousa C
    Eur J Immunol; 2003 Apr; 33(4):827-33. PubMed ID: 12672047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine thymic plasmacytoid dendritic cells.
    Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
    Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
    Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
    Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.
    Gatti G; Nuñez NG; Nocera DA; Dejager L; Libert C; Giraudo C; Maccioni M
    Eur J Immunol; 2013 Jul; 43(7):1849-61. PubMed ID: 23636788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
    Kunzmann V; Kretzschmar E; Herrmann T; Wilhelm M
    Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.
    Diebold SS; Montoya M; Unger H; Alexopoulou L; Roy P; Haswell LE; Al-Shamkhani A; Flavell R; Borrow P; Reis e Sousa C
    Nature; 2003 Jul; 424(6946):324-8. PubMed ID: 12819664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
    Ahonen CL; Doxsee CL; McGurran SM; Riter TR; Wade WF; Barth RJ; Vasilakos JP; Noelle RJ; Kedl RM
    J Exp Med; 2004 Mar; 199(6):775-84. PubMed ID: 15007094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.
    Diebold SS; Kaisho T; Hemmi H; Akira S; Reis e Sousa C
    Science; 2004 Mar; 303(5663):1529-31. PubMed ID: 14976261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
    Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
    J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.
    Hornung V; Guenthner-Biller M; Bourquin C; Ablasser A; Schlee M; Uematsu S; Noronha A; Manoharan M; Akira S; de Fougerolles A; Endres S; Hartmann G
    Nat Med; 2005 Mar; 11(3):263-70. PubMed ID: 15723075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid).
    Westwood A; Elvin SJ; Healey GD; Williamson ED; Eyles JE
    Vaccine; 2006 Mar; 24(11):1736-43. PubMed ID: 16278038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
    Conforti R; Ma Y; Morel Y; Paturel C; Terme M; Viaud S; Ryffel B; Ferrantini M; Uppaluri R; Schreiber R; Combadière C; Chaput N; André F; Kroemer G; Zitvogel L
    Cancer Res; 2010 Jan; 70(2):490-500. PubMed ID: 20068181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.